Revvity, Inc revenue by segment RVTY

Annual Quarterly

Revvity, Inc splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jul 5, 2026 was Diagnostics at $371.0 million, 51% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jul 5, 2026 was Product at $603.4 million, 83% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jul 5, 2026	Q2 FY2026 Jul 5, 2026	Q1 FY2026 Apr 5, 2026	Q4 FY2025 Dec 28, 2025	Q3 FY2025 Sep 28, 2025	Q2 FY2025 Jun 29, 2025	Q1 FY2025 Mar 30, 2025	Q4 FY2024 Dec 29, 2024	Q3 FY2024 Sep 29, 2024
Revenue	2,912	730	711	772	699	720	665	729	684
Operating segments
Diagnostics	1,466 +6.4% share 50.4%	371 +4.7% share 50.8%	349 +7.7% share 49.1%	390 -21.8% share 50.5%	356 +3.2% share 51.0%	354 share 49.2%	324 share 48.8%	499 share 68.4%	345 share 50.5%
Life Sciences	1,445 +1.8% share 49.6%	359 -2.0% share 49.2%	362 +6.3% share 50.9%	382 +65.9% share 49.5%	343 +1.2% share 49.0%	366 share 50.8%	340 share 51.2%	230 share 31.6%	339 share 49.5%
Sales mix
Product	2,405 +1.5% share 82.6%	603 -1.2% share 82.7%	581 +3.3% share 81.8%	647 +4.3% share 83.8%	573 -1.2% share 82.0%	611 share 84.8%	563 share 84.6%	620 share 85.0%	580 share 84.8%
Services	507 +18.3% share 17.4%	126 +15.2% share 17.3%	130 +27.0% share 18.2%	125 +14.6% share 16.2%	126 +20.8% share 18.0%	110 share 15.2%	102 share 15.4%	109 share 15.0%	104 share 15.2%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: RVTY (NYSE)
Fiscal year ends: December 29
Incorporated in: MA
Headquarters: Waltham, MA
SEC filer status: Large accelerated filer
SEC CIK: 31791
Former names: PERKINELMER INC (until Apr 14, 2023); EG&G INC (until Jul 26, 1999)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.